Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota.
Division of Sleep Medicine, Mayo Clinic, Rochester, Minnesota.
J Clin Sleep Med. 2019 May 15;15(5):769-777. doi: 10.5664/jcsm.7772.
Many patients struggle with adherence to positive airway pressure (PAP) therapy for sleep apnea. In this systematic review we examined the effect that patient-facing applications (PFA)-web-based applications that interact directly with the patient-have on PAP adherence.
A comprehensive search of PubMed, CINAHL, MEDLINE, and SCOPUS databases was performed. We looked for studies where: (1) patients were adults with sleep apnea initiating PAP therapy for the first time; (2) the intervention was a PFA that incorporated individual PAP use data; (3) the comparison was usual and/or telemedicine care, and (4) outcomes of objective PAP adherence data were recorded.
Seven studies were identified (two randomized trials, one prospective cohort trial, four retrospective cohort studies). Cumulatively the studies enrolled 304,328 patients, with individual enrollment ranging between 61 and 172,678 patients. Six studies showed that PFA use was associated with using PAP for significantly more hours per night (range 0.7-1.3 hours more). PFA cohorts used PAP a greater proportion of nights and had a lower rate of mask leak. There was no difference in apnea-hypopnea index and self-reported measures of symptoms between study groups.
PFA use was associated with improved adherence to PAP therapy. Although this conclusion is based on only two small trials and predominantly observational studies and therefore should be tested in large prospective trials, the PAFs are inexpensive, do not draw on health care resources, and show promise in improving PAP therapy for OSA.
许多患者在使用正压通气(PAP)治疗睡眠呼吸暂停时难以坚持治疗。在本系统评价中,我们考察了直接与患者互动的患者面应用程序(PFA)-基于网络的应用程序对 PAP 依从性的影响。
对 PubMed、CINAHL、MEDLINE 和 SCOPUS 数据库进行了全面检索。我们寻找了以下研究:(1)患者为首次开始 PAP 治疗的睡眠呼吸暂停成年患者;(2)干预措施为整合了个体 PAP 使用数据的 PFA;(3)比较为常规和/或远程医疗护理;(4)记录了客观 PAP 依从性数据的结果。
确定了 7 项研究(2 项随机试验、1 项前瞻性队列试验、4 项回顾性队列研究)。这些研究共纳入了 304328 名患者,个体入组范围为 61 至 172678 名患者。有 6 项研究表明,PFA 的使用与每晚使用 PAP 的时间显著增加(增加 0.7-1.3 小时)相关。PFA 队列使用 PAP 的比例更高,面罩漏风率更低。两组之间的睡眠呼吸暂停低通气指数和自我报告的症状测量没有差异。
PFA 的使用与 PAP 治疗依从性的提高有关。尽管这一结论仅基于两项小型试验和主要的观察性研究,因此应该在大型前瞻性试验中进行检验,但 PFA 价格低廉,不占用医疗资源,并有望改善 OSA 的 PAP 治疗。